Skip to main content
. 2004 May 17;199(10):1391–1399. doi: 10.1084/jem.20040111

Table V.

Mortality According to MBL Deficiency Genotype during 8 yr Follow-up

Noncarriers
Heterozygotes
Homozygotes
IncidenceN/10,000person · yr RRa IncidenceN/10,000person · yr P-valueb RRa (95% CI) IncidenceN/10,000
person · yr
P-valueb RRa(95% CI)
Death from any cause 235 1.0 244 0.44 1.0 (0.95–1.2) 274 0.12 1.1 (0.87–1.3)
Infectious and parasitic diseases 1.9 1.0 2.7 0.53 1.5 (0.52–4.2) 2.6 0.78 1.4 (0.17–13)
Respiratory infections 4.3 1.0 2.7 0.40 0.66 (0.28–1.6) 2.6 0.61 0.44 (0.05–3.6)
Respiratory disorders 14 1.0 10 0.14 0.73 (0.45–1.2) 18 0.56 1.2 (0.54–2.7)
Cardiovascular disorders 41 1.0 31 0.04 0.73 (0.55–0.95) 49 0.44 1.1 (0.70–1.8)
Malignant neoplasms 58 1.0 63 0.45 1.1 (0.90–1.3) 78 0.13 1.3 (0.87–1.9)
Digestive disorders 7.0 1.0 5.3 0.41 0.82 (0.42–1.6) 5.2 0.69 0.66 (0.15–2.8)
Musculoskeletal disorders 1.4 1.0 0 0
Neuropsychiatric disorders 3.4 1.0 3.4 0.96 1.4 (0.56–3.3) 0
a

Relative risks (RR) were adjusted for age, gender, smoking habits, systolic blood pressure, alcohol, cholesterol, body mass index, and physical inactivity.

b

P-values by log-rank test. Infectious and parasitic diseases: 001–136, 320, 323, 612–614, 620, 622, A00–B99, G00, G03–G04, N70–N73; respiratory infections: 460–486, 381–382, J00–J22, H65–H66; respiratory disorders: 490–519, J30–J99; cardiovascular disorders: 390–458, I00–I99; malignant neoplasms: 140–209, C00–C97; digestive disorders: 530–577, K20–K99; musculoskeletal disorders: 710–738, M00–M99; neuropsychiatric disorders: 290–315, 321–322, 324–358, F01–F99, G06–G98.